33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-33.47
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
38.46
P/S 1.25-1.5x PATH's 27.57. Martin Whitman would scrutinize if premium reflects better growth prospects.
7.65
P/B above 1.5x PATH's 4.43. Michael Burry would check for potential asset overvaluation.
-691.60
Negative FCF while PATH shows P/FCF of 92.70. Joel Greenblatt would examine cash flow improvement potential.
-1640.99
Negative operating cash flow while PATH shows P/OCF of 90.53. Joel Greenblatt would examine operational improvement potential.
7.65
Fair value ratio above 1.5x PATH's 4.43. Michael Burry would check for mean reversion risks.
-0.75%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-0.14%
Negative FCF while PATH shows yield of 1.08%. Joel Greenblatt would examine cash flow improvement potential.
